Asthma

The Role of Viral Infections in Asthma Development and Outcomes

By

Tori Rodriguez, MA, LPC, AHC

Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.

Exercise-Induced Bronchoconstriction With or Without Asthma: A Unique Challenge

By

Tori Rodriguez, MA, LPC, AHC

Patients with asthma who underwent exercise training have shown improvements in symptoms, pulmonary function, exercise capacity, and quality of life.

The Bidirectional Nature of Asthma and Obstructive Sleep Apnea

By

Tori Rodriguez, MA, LPC, AHC

Obstructive sleep apnea was positively associated with worse outcomes in patients hospitalized because of asthma exacerbations, including increased costs, longer lengths of stay, and the need for invasive respiratory therapy.

Expert AI-Based Natural Language Processing Algorithms May Identify Childhood Asthma

By

Virginia A. Schad, PharmD, RPh

Expert artificial intelligence-based natural language processing algorithms may help clinicians and researchers systematically identify childhood asthma and its subgroups with distinctive characteristics from electronic health records.

Lower Remission Rate in Asthma May Be Linked to Age at Diagnosis

By

Melissa I. Alvarez

Late-diagnosed asthma was identified as the most independent significant risk factor for non-remission in patients with asthma.

Cognition, Symptom Perception Relationship Examined in Older Adults With Asthma

By

Sheila Jacobs

Cognitive impairment does not affect symptom perception in older adults with asthma.

Many Young Patients With Asthma Do Not Comply With COVID-19 Prevention Measures

A substantial percentage of young patients with asthma do not comply with COVID-19 prevention measures.

Assessing the Effectiveness of Nebulized Magnesium With Albuterol in Pediatric Refractory Asthma

By

Sheila Jacobs

In children with refractory acute asthma who present to the emergency department, the use of nebulized magnesium with albuterol, compared with placebo, does not significantly decrease hospitalization rates for asthma in the first 24 hours.